Drug intelligence / Profile preview

prebiotic oligosaccharides mixture II

Development stage
Unknown
Lead developer
Danone
Modality
Microbiome-Derived Products → Microbiome Therapeutics
Administration
Oral
01

Overview

"Prebiotic oligosaccharides mixture II" refers to a specific formulation developed by Danone/Nutricia, consisting of a proprietary blend of short-chain galacto-oligosaccharides (scGOS) and long-chain fructo-oligosaccharides (lcFOS) in a 9:1 ratio. This mixture is designed to mimic the diversity and function of oligosaccharides found in human breast milk. [7, 8, 9] As a prebiotic, it is not digested in the upper gastrointestinal tract and reaches the colon, where it serves as a substrate for beneficial gut bacteria, selectively stimulating the growth of species like *Bifidobacteria* and *Lactobacilli*. [8] It is primarily used as a key ingredient in infant formulas to support the development of a healthy gut microbiome, which is associated with improved stool characteristics and beneficial effects on the immune system. [8, 9] The specific term "prebiotic oligosaccharides mixture II" was used to identify this intervention in a clinical trial (NCT01507935) sponsored by Danone to study its effects on gut microbiota in healthy infants. [1, 12]

Other names
scGOS/lcFOS (9:1)short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1)

Beyond the preview

Go deeper on prebiotic oligosaccharides mixture II.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on prebiotic oligosaccharides mixture II.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call